Summary
We measured the 24-h excretion of urinary kallikrein in 27 patients with Type 2 (non-insulin-dependent) diabetes and in 10 normal control subjects. Mean (± SD) kallikrein excretion in diabetic patients with nephropathy (6.2±2.4 naphthyl units (NU)/day,n=13) was significantly lower than in control subjects (12.8±3.4NU/day,p<0.01) and in diabetic patients without nephropathy (9.4±3.4NU/day,n=14,p<0.05). Kallikrein excretion in hypertensive diabetic patients with nephropathy (5.1±1.6 NU/day,n=8) was significantly lower (p<0.05) than in normotensive patients with nephropathy (8.3±2.1 NU/day,n=5). There were no significant differences in kallikrein excretion rate (24-h excretion of urinary kallikrein/24-h creatinine clearance) among control subjects (9.9±4.3 NU/ml), diabetic patients with (9.0±3.2 NU/ml) and without (9.3±3.5 NU/ml) nephropathy. However, kallikrein excretion rate in hypertensive diabetic patients with nephropathy (7.7±3.3 NU/ml) was significantly lower (p<0.05) than in normotensive diabetic patients with nephropathy (11.8 ±2.0 NU/ml,n=10). Respective basal and post-stimulated (with intravenous furosemide 40 mg plus 60 min ambulation) plasma aldosterone concentrations measured in control subjects and in hypertensive diabetic patients with nephropathy were similar and increased to the same extent in the 2 groups (5.5±3.2 versus 5.3±3.2 and 9.3±2.6 versus 10.5±3.4 ng/ml), although the respective plasma renin activity tended to be lower in diabetic patients than in control subjects (0.7±0.6 versus 1.3±0.9 and 1.8±1.8 versus 3.0±2.6 ng−1 · ml−1 · h−1). The results indicate that urinary kallikrein excretion is decreased in hypertensive diabetic patients with nephropathy, and that the decrease might not be attributable to an altered renin-aldosterone system.
Article PDF
Similar content being viewed by others
References
Moss AJ (1962) Blood pressure in children with diabetes mellitus. Pediatrics 130: 932–936
Pell S, D'Alonzo CA (1967) Some aspects of hypertension in diabetes mellitus. J Am Med Assoc 202: 104–110
Pell S, D'Alonzo CA (1971) Factors associated with long-term survival of diabetes. J Am Med Assoc 214: 1833–1844
White P (1956) Natural course and prognosis of juvenile diabetes. Diabetes 5: 445–450
Baba T, Murabayashi S, Aoyagi K, Sasaki K, Imamura K, Kudo M, Takebe K (1985) Prevalence of hypertension in diabetes mellitus: Its relation to diabetic nephropathy. Tohoku J Exp Med 145: 167–173
Christlieb AR, Kaldany A, D'Elia JA (1976) Plasma renin activity and hypertension. Diabetes 25: 969–974
Perez GO, Lespier L, Jacobi J, Oster JR, Katz FH, Baamonde CA, Fishman L (1977) Hyporeninemia and hypoaldosteronism in diabetes mellitus. Arch Int Med 137: 852–855
Fernandez-Cruz A, Noth RH, Lassman MN, Hollis JB, Mulrow PJ (1981) Low plasma renin activity in normotensive patients with diabetes mellitus: Relationship to neuropathy. Hypertension 3: 87–92
Tomita K, Matsuda O, Ideura T, Shiigai T, Takeuchi J (1982) Renin-angiotensin-aldosterone system in mild diabetic nephropathy. Nephron 31: 361–367
Wilson TW, Tan LK (1985) Low plasma renin activity in diabetes: Relation to urine prostaglandin excretion. Diabetes 34: 145–150
Carretero OA, Scicli AG (1981) Possible role of kinins in circulatory homeostasis. Hypertension 3 (Suppl 1): 4–12
National Diabetes Data Group (1979) Classification of diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Miles DW, Mogensen CE, Gundersen HJG (1970) Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 26: 5–11
Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430–1432
Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89–93
Hitomi Y, Niinobe M, Fujii S (1980) A sensitive colorimetric assay for human urinary kallikrein. Clin Chim Acta 100: 275–283
Haber E, Koerner T, Page LB, Klinman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349–1355
Ogihara T, Iinuma K, Nishi K, Arakawa Y, Takagi A, Kurata K, Miyai K, Kumahara Y (1977) A non-chromatographic non-extraction radioimmunoassay for serum aldosterone. J Clin Endocrinol Metab 45: 726–731
Davis JE, McDonald JM, Jarrett L (1978) A high-performance liquid chromatography method for hemoglobin A1c. Diabetes 27: 102–107
Nustad K, Vaaje K, Pierce JV (1975) Synthesis of kallikreins by rat kidney slices. Br J Pharmacol 53: 229–234
Roblero J, Croxatto H, Garcia R, Corthorn J, De Vito E (1976) Kallikrein-like activity in perfusates and urine of isolated rat kidneys. Am J Physiol 231: 1383–1389
Scicli AG, Carretero OA, Hampton A, Cortes P, Oza NB (1976) Site of kininogenase secretion in the dog nephron. Am J Physiol 230: 533–536
Nustad K (1970) The relationship between kidney and urinary kininogenase. Br J Pharmacol 39: 73–86
Margolius HS, Geller RG, Pisano JJ, Sjoerdsma A (1971) Altered urinary kallikrein excretion in human hypertension. Lancet 2: 1063–1065
Lechi A, Covi G, Lechi C, Mantero F, Scuro LA (1976) Urinary kallikrein excretion in Bartter's syndrome. J Clin Endocrinol Metab 43: 1175–1178
Rapelli A, Dessi-Fulgheri P, Mededdu P, Leoni C, Fiori C, Cocco F, Sanna G, Glorioso N (1982) Plasma active and inactive renin and urinary kallikrein in normal subjects in response to hydrochlorothiazide, spironolactone or aldosterone administration. Clin Exp Hypertens 4: 2273–2283
Elliot AH, Nazum FR (1934) The urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 18: 462–474
Keiser HR, Geller RG, Margolius HS, Pisano JJ (1976) Urinary kallikrein in hypertensioe animal models. Fed Proc 35: 199–202
Mitas JA, Levy SB, Holle R, Frigon P, Stone RA (1978) Urinary kallikrein activity in the hypertension of renal parenchymal disease. N Engl J Med 299: 162–165
Glasser RJ, Michael AF (1976) Urinary kallikrein in experimental renal disease. Lab Invest 34: 616–622
Ørstavik TB (1980) The kallikrein-kinin system in exocrine organs. J Histochem Cytochem 28: 881–889
Scicli AG, Gandolfi R, Carretero OA (1978) Site of formation of kinins in the dog nephron. Am J Physiol 234: 1736–1740
Geller RG, Margolius HS, Pisano JJ, Keiser HR (1972) Effects of mineralocorticoids, altered sodium intake and adrenalectomy on urinary kallikrein in rats. Cir Res 31: 857–861
Kaizu T, Margolius HS (1975) Studies on rat renal cortical cell kallikrein. I. Separation and measurement. Biochim Biophys Acta 411: 305–315
DeLeiva A, Christlieb AR, Melby JC, Graham CA, Day RP, Leutscher JA, Zager PG (1976) Big renin and biosynthetic defect of aldosterone in diabetes mellitus. N Engl J Med 295: 639–643
Fritschka E, Gotzen R, Kittler R, Schoneshofer M (1984) Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension. Br J Pharmacol 81: 245–253
Fraser DM, Campbell IW, Ewing DJ, Murray A, Neilson JMM, Clarke BF (1977) Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes 26: 546–550
Dyrberg TM, Benn J, Sandahl CJ, Hilsted J, Nerup J (1981) Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia 20: 190–194
Levy SB, Lilley JJ, Frigon RP, Stone RA (1977) Urinary kallikrein and plasma renin activity as determinants of renal blood flow: the influence of race and dietary sodium intake. J Clin Invest 60: 129–138
Adetuyibi A, Milles IH (1972) Relation between urinary kallikrein and renal function, hypertension and exretion of sodium and water in man. Lancet 2: 203–207
Milles IH, Ward PE (1975) The relationship between kallikrein and water excretion and the conditional relationship between kallikrein and sodium excretion. J Physiol 246: 695–707
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baba, T., Murabayashi, S., Ishizaki, T. et al. Renal kallikrein in diabetic patients with hypertension accompanied by nephropathy. Diabetologia 29, 162–167 (1986). https://doi.org/10.1007/BF02427087
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02427087